dopamine 3-o-sulfate has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, T; Mizutani, Y; Nabeshima, T; Ogawa, M; Okada, Y | 1 |
| Eichinger, K; Fuchs, G; Jellinger, K; Kienzl, E; Kuhn, W; Laux, G; Riederer, P; Sofic, E | 1 |
2 other study(ies) available for dopamine 3-o-sulfate and Parkinson Disease
| Article | Year |
|---|---|
Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients.
Topics: Administration, Oral; Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Models, Biological; Parkinson Disease | 1995 |
Urinary dopamine sulfate: regulations and significance in neurological disorders.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Dopamine; Female; Humans; Male; Middle Aged; Nervous System Diseases; Parkinson Disease | 1990 |